VIACELL, INC. FORM 8-K
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 9, 2005
VIACELL, INC.
 
(Exact name of registrant as specified in its charter)
         
Delaware   000-51110   04-3244816
         
(State or other jurisdiction of
of incorporation or organization) 		  (Commission
File Number) 		  (I.R.S. Employer
Identification No.)
245 First Street, Cambridge, Massachusetts 02142
 
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (617) 914-3400
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 2.02. Results of Operations and Financial Condition
Item 9.01 Financial Statements and Exhibits.
SIGNATURE
INDEX TO EXHIBITS
EX-99.1 PRESS RELEASE DATED AUGUST 9, 2005

Table of Contents

Item 2.02. Results of Operations and Financial Condition
     On August 9, 2005, ViaCell, Inc. issued a press release relating to its results of operations and financial condition for the quarter ended June 30, 2005. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(c)   Exhibits
  99.1   Press Release of ViaCell, Inc. dated August 9, 2005.

 

Table of Contents

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  VIACELL, INC.
 		  
  By:   /s/ STEPHEN DANCE    
    Name:   Stephen Dance   
Date: August 9, 2005    Title:   Chief Financial Officer   
 

 

Table of Contents

INDEX TO EXHIBITS
         
Exhibit No.   Description
       
 
  99.1    
Press Release of ViaCell, Inc. dated August 9, 2005.